Assessment of 24,25(OH)2D levels does not support FGF23-mediated catabolism of vitamin D metabolites

Progressive elevations of fibroblastic growth factor 23 [FGF23] in chronic kidney disease may reduce serum 25-hydroxyvitamin D [25(OH)] and 1,25-dihydroxyvitamin D [1,25(OH)2D] levels, via stimulation of 24-hydroxylase (Cyp24A1) mediated catabolism of these vitamin D metabolites. To test this possib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dai, Bing, David, Valentin, Alshayeb, Hala M., Showkat, A., Gyamlani, G, Horst, Ronald L., Wall, Barry M., Quarles, L. Darryl
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3461248/
https://ncbi.nlm.nih.gov/pubmed/22739976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2012.222
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados